What should you know about fluorescent immunohistochemistry?

A pathologist prepares thin sections from a biopsy and applies antibodies that recognise chosen proteins. Each antibody carries a fluorescent label. Under a suitable microscope, the label appears as a signal in the cells or tissue structures where its target is present. The location and pattern of that signal can add detail to the appearance of the tissue under ordinary microscopy.

This information may help characterise a tumour, distinguish similar-looking conditions, or assess a marker relevant to treatment decisions. A fluorescent signal does not automatically mean that cancer is present. The finding must be read with the tissue architecture, the biopsy diagnosis, the quality of the sample, and other laboratory results.

Ask which protein or proteins were tested and whether the report describes the result as present, absent, weak, strong, or showing a particular pattern. The meaning can depend on where the signal appears and how many cells show it. Tell your doctor about previous biopsies and treatment, because tissue handling or treatment-related changes can affect interpretation. Ask whether another stain or test is needed before a treatment decision is made.

Fluorescent immunohistochemistry is performed on tissue in a laboratory, so it does not cause symptoms by itself. Seek help based on the biopsy procedure or the condition being investigated. Contact the clinical team for increasing pain, redness, swelling, drainage, fever, or bleeding from a biopsy site. Use urgent services for severe bleeding, breathing difficulty, faintness, or rapidly worsening symptoms.

Consider asking: Which marker was tested? Where was it found in the tissue? Does the pattern change the diagnosis or treatment options? Was the sample sufficient? Will the result be reviewed in a specialist meeting or alongside additional pathology tests?